SCHEDULE: Hezbay Holdings Reports 9.54% Stake in Matinas BioPharma

Hezbay Holdings LLC has disclosed a beneficial ownership of 9.54% in Matinas BioPharma Holdings Inc. common stock as of July 13, 2026.

Summary

• Hezbay Holdings LLC has filed a Schedule 13G, indicating beneficial ownership of 1,306,488 shares of Matinas BioPharma Holdings Inc. common stock.
• This ownership stake represents 9.54% of the class of securities outstanding as of July 10, 2026.
• Hezbay Holdings LLC holds sole voting power and sole dispositive power over these shares.
• The filing notes that the aggregate amount of shares beneficially owned excludes shares purchasable pursuant to preferred shares and warrants due to a 4.99% ownership restriction.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of beneficial ownership without commentary on company performance or future strategy.

Positives

• Hezbay Holdings LLC has established a significant ownership position in Matinas BioPharma Holdings Inc., holding 9.54% of the outstanding common stock.
• The reporting person has sole voting and dispositive power, indicating direct control over their stake.

Negatives

• The filing explicitly excludes shares from preferred stock and warrants due to a 4.99% ownership restriction, suggesting potential limitations on further acquisition or control.

Risks

• Potential for future regulatory scrutiny if ownership levels approach or exceed contractual restrictions.
• Market perception of concentrated ownership could lead to increased volatility.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance. It is a disclosure of current ownership status.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant stakeholders to disclose their holdings in publicly traded companies, indicating a notable investment by Hezbay Holdings LLC in the biopharmaceutical sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by Hezbay Holdings LLC may influence market perception and trading activity.
• Management of Matinas BioPharma Holdings Inc.: May need to engage with Hezbay Holdings LLC regarding their investment strategy and potential influence.

Next Steps

• Hezbay Holdings LLC will continue to hold its shares in Matinas BioPharma Holdings Inc., subject to any contractual restrictions.
• Matinas BioPharma Holdings Inc. will continue its operations as a biopharmaceutical company.

Key Dates

Keywords

Matinas BioPharma Holdings Inc., Hezbay Holdings LLC, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment, Ownership Stake